Literature DB >> 7546834

Expression and regulation of cyclin genes in breast cancer.

R L Sutherland1, J A Hamilton, K J Sweeney, C K Watts, E A Musgrove.   

Abstract

Cyclins, the regulatory subunits of cyclin-dependent kinases, control passage through key check-points within the cell cycle. Since dysregulated expression and function of cyclins can lead to loss of normal growth control some of these genes are oncogenes. We have studied cyclin gene expression, regulation and function in breast cancers. Induction of cyclin D1 is an early event in mitogenic stimulation of breast cancer cells by growth factors and steroids. Furthermore, inhibition of cyclin D1 expression is an early response to growth inhibition by antioestrogens. Ectopic expression of cyclin D1 in T-47D breast cancer cells demonstrated that cyclin D1 is rate-limiting for progression through G1 phase and is sufficient for growth arrested cells to complete the cell cycle. Since this gene is frequently overexpressed in human breast cancers it may contribute to the development and progression of some breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546834     DOI: 10.3109/02841869509094043

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas.

Authors:  J S de Jong; P J van Diest; R J Michalides; J P Baak
Journal:  Mol Pathol       Date:  1999-04

2.  Dissecting the roles of beta-catenin and cyclin D1 during mammary development and neoplasia.

Authors:  Tracey M Rowlands; Irina V Pechenkina; Sarah J Hatsell; Richard G Pestell; Pamela Cowin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.

Authors:  B S Shoker; C Jarvis; M P Davies; M Iqbal; D R Sibson; J P Sloane
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

Review 4.  Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Authors:  R I Nicholson; J M Gee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

5.  Kinesin family member 11 contributes to the progression and prognosis of human breast cancer.

Authors:  Yuan-Yuan Pei; Gao-Chi Li; Jian Ran; Feng-Xiang Wei
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

6.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

7.  Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro.

Authors:  K Sugiyama; M Shimizu; T Akiyama; H Ishida; M Okabe; T Tamaoki; S Akinaga
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.